BKD icon

Brookdale Senior Living

5.87 USD
-0.37
5.93%
At close Apr 21, 4:00 PM EDT
Pre-market
5.40
-0.47
8.01%
1 day
-5.93%
5 days
2.26%
1 month
-2.49%
3 months
16.24%
6 months
-6.53%
Year to date
16.01%
1 year
-11.06%
5 years
82.87%
10 years
-84.08%
 

About: Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

Employees: 36,000

0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

50% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 3 (+1) [Q4]

3% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 62

2.28% less ownership

Funds ownership: 107.63% [Q3] → 105.35% (-2.28%) [Q4]

12% less funds holding

Funds holding: 196 [Q3] → 172 (-24) [Q4]

22% less capital invested

Capital invested by funds: $1.44B [Q3] → $1.12B (-$318M) [Q4]

49% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 43

81% less call options, than puts

Call options by funds: $282K | Put options by funds: $1.49M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$7.50
28%
upside
Avg. target
$7.83
33%
upside
High target
$8
36%
upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Barclays
Steve Valiquette
56% 1-year accuracy
5 / 9 met price target
28%upside
$7.50
Equal-Weight
Maintained
16 Apr 2025
RBC Capital
Ben Hendrix
37% 1-year accuracy
24 / 65 met price target
36%upside
$8
Outperform
Reiterated
10 Apr 2025
Macquarie
Tao Qiu
30% 1-year accuracy
6 / 20 met price target
36%upside
$8
Outperform
Maintained
12 Mar 2025

Financial journalist opinion

Based on 9 articles about BKD published over the past 30 days

Neutral
Zacks Investment Research
20 hours ago
Take the Zacks Approach to Beat the Markets: Pro-Dex, Brookdale Senior Living, Coca-Cola in Focus
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Take the Zacks Approach to Beat the Markets: Pro-Dex, Brookdale Senior Living, Coca-Cola in Focus
Positive
Zacks Investment Research
4 days ago
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Here is how Brookdale Senior Living (BKD) and Claritev Corporation (CTEV) have performed compared to their sector so far this year.
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Neutral
PRNewsWire
1 week ago
Brookdale Announces CEO Transition and Board of Directors Refreshment
Board Initiates Search for New CEO, Appoints Interim CEO and Establishes Office of the CEO  Mark Fioravanti Appointed as New Independent Director; Frank M. Bumstead Will Not Stand for Reelection at the 2025 Annual Meeting Board to Review Potential Enhancements to Corporate Governance Policies  First Quarter 2025 Preliminary Results Exceed Brookdale Expectations NASHVILLE, Tenn.
Brookdale Announces CEO Transition and Board of Directors Refreshment
Neutral
Business Wire
1 week ago
Antipodes Calls for a Strategic Update and Corporate Governance Improvements at Brookdale Senior Living Inc.
SYDNEY--(BUSINESS WIRE)--Antipodes Partners Ltd., a Sydney-based global asset management firm currently overseeing approximately US$13 billion in client assets, has issued a letter to fellow shareholders and the Board of Directors of Brookdale Senior Living (NYSE: BKD). The asset manager highlights attractive fundamentals of the senior housing industry and estimates that the intrinsic value of BKD shares may exceed $30 per share, compared to a 52-week trading range of $4.45 to $8.12. Antipodes.
Antipodes Calls for a Strategic Update and Corporate Governance Improvements at Brookdale Senior Living Inc.
Neutral
PRNewsWire
1 week ago
Brookdale Reports March 2025 Occupancy
NASHVILLE, Tenn. , April 8, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for March 2025.
Brookdale Reports March 2025 Occupancy
Positive
Zacks Investment Research
3 weeks ago
Why Fast-paced Mover Brookdale (BKD) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Why Fast-paced Mover Brookdale (BKD) Is a Great Choice for Value Investors
Positive
Zacks Investment Research
3 weeks ago
Wall Street Analysts See a 25.3% Upside in Brookdale (BKD): Can the Stock Really Move This High?
The consensus price target hints at a 25.3% upside potential for Brookdale (BKD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts See a 25.3% Upside in Brookdale (BKD): Can the Stock Really Move This High?
Neutral
PRNewsWire
3 weeks ago
Brookdale Announces Election of Early Settlement of its Purchase Contracts
NASHVILLE, Tenn. , March 27, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") today announced that it has elected to exercise its right to settle all of its prepaid stock purchase contracts, pursuant to the early settlement right in the purchase contract agreement.
Brookdale Announces Election of Early Settlement of its Purchase Contracts
Positive
Zacks Investment Research
3 weeks ago
Should Value Investors Buy Brookdale Senior Living (BKD) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Brookdale Senior Living (BKD) Stock?
Positive
Zacks Investment Research
1 month ago
Is Brookdale Senior Living (BKD) Stock Outpacing Its Medical Peers This Year?
Here is how Brookdale Senior Living (BKD) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Is Brookdale Senior Living (BKD) Stock Outpacing Its Medical Peers This Year?
Charts implemented using Lightweight Charts™